{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T19:39:53Z","timestamp":1715110793659},"reference-count":10,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"DOI":"10.1007\/s00105-021-04784-7","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T15:04:29Z","timestamp":1615302269000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Erfolgreiche Behandlung einer generalisierten pustul\u00f6sen Psoriasis mit Certolizumab"],"prefix":"10.1007","author":[{"given":"Hannah","family":"Post","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Magnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"4784_CR1","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1038\/jid.2013.361","volume":"133","author":"F Capon","year":"2013","unstructured":"Capon\u00a0F (2013) IL36RN mutations in generalized pustular psoriasis: just the tip of the iceberg? J\u00a0Invest Dermatol 133:2503\u20132504","journal-title":"J Invest Dermatol"},{"key":"4784_CR2","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/jdv.14949","volume":"32","author":"KM Hoegler","year":"2018","unstructured":"Hoegler\u00a0KM, John\u00a0AM, Handler\u00a0MZ, Schwartz\u00a0RA (2018) Generalized pustular psoriasis: a review and update on treatment. J\u00a0Eur Acad Dermatol Venereol 32:1645\u20131651","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4784_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","volume":"77","author":"X Mariette","year":"2018","unstructured":"Mariette\u00a0X, F\u00f6rger\u00a0F, Abraham\u00a0B, Flynn\u00a0AD, Molt\u00f3\u00a0A, Flipo\u00a0R\u2011M, van Tubergen\u00a0A, Shaughnessy\u00a0L, Simpson\u00a0J, Teil\u00a0M, Helmer\u00a0E, Wang\u00a0M, Chakravarty\u00a0EF (2018) Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a\u00a0prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis 77:228\u2013233","journal-title":"Ann Rheum Dis"},{"key":"4784_CR4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40265-019-01136-7","volume":"79","author":"K McKaege","year":"2019","unstructured":"McKaege\u00a0K, Duggan\u00a0S (2019) Risankizumab: first global approvement. Drugs 79:893\u2013900","journal-title":"Drugs"},{"key":"4784_CR5","first-page":"e262","volume":"47","author":"Y Mizutani","year":"2020","unstructured":"Mizutani\u00a0Y, Mizutani\u00a0YH, Matsuyama\u00a0K, Kawamura\u00a0M, Fujii\u00a0A, Shu\u00a0E, Ohnishi\u00a0H, Seishima\u00a0M (2020) Generalized pustular psoriasis in pregnancy, successfully treated with certolizumab pegol. J\u00a0Dermatol 47:e262\u2013e263","journal-title":"J Dermatol"},{"key":"4784_CR6","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon\u00a0A, Sch\u00e4kel\u00a0K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:1475","journal-title":"Int J Mol Sci"},{"key":"4784_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jaad.2011.01.032","volume":"67","author":"A Robinson","year":"2012","unstructured":"Robinson\u00a0A, Van Voorhees\u00a0AS, Hsu\u00a0S, Korman\u00a0NJ, Lebwohl\u00a0MG, Bebo\u00a0BF Jr, Kalb\u00a0RE (2012) Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J\u00a0Am Acad Dermatol 67:279\u2013288","journal-title":"J Am Acad Dermatol"},{"key":"4784_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1046\/j.1468-3083.2003.00715.x","volume":"17","author":"E Vocks","year":"2003","unstructured":"Vocks\u00a0E, Worret\u00a0W\u2011I, Ring\u00a0J (2003) Erythema annulare centrifugum-type psoriasis: a\u00a0particular variant of acute-eruptive psoriasis. J\u00a0Eur Acad Dermatol Venereol 17:446\u2013448","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4784_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14740338.2020.1785427","volume":"19","author":"W-M Wang","year":"2020","unstructured":"Wang\u00a0W\u2011M, Jin\u00a0HG (2020) Biologics in the treatment of pustular psoriasis. Expert Opin Drug Saf 19:969\u2013999","journal-title":"Expert Opin Drug Saf"},{"key":"4784_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00105-016-3804-4","volume":"67","author":"P Weisenseel","year":"2016","unstructured":"Weisenseel\u00a0P, Wilsmann-Theis\u00a0D, Kahl\u00a0C, Reich\u00a0K, M\u00f6ssner\u00a0R (2016) Pustular psoriasis. Hautarzt 67:445\u2013453","journal-title":"Hautarzt"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04784-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-021-04784-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04784-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T15:17:44Z","timestamp":1615303064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-021-04784-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":10,"alternative-id":["4784"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04784-7","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"10 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Post gibt an, dass kein Interessenkonflikt besteht. N.\u00a0Magnolo hat f\u00fcr Vortr\u00e4ge Honorare von UCB erhalten. Sie war Principal Investigator klinischer Studien, gesponsert von UCB. M.\u00a0B\u00f6hm war Berater f\u00fcr UCB und hat f\u00fcr Vortr\u00e4ge Honorare erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}